Amneal Pharmaceuticals, Inc. Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Amneal Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Amneal Pharmaceuticals, Inc. for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Option Exercise | M | 2.75 | 36,330 | 99,908 | 36,331 | |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Sell | S | 6.82 | 36,330 | 247,865 | 279,940 | 316.3 K to 279.9 K (-11.49 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Todisco Joseph | Executive Vice Pres ... | Buy | M | 2.75 | 36,330 | 99,908 | 316,270 | 279.9 K to 316.3 K (+12.98 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 2.75 | 36,330 | 99,908 | 36,331 | |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Sell | S | 6.87 | 36,330 | 249,489 | 211,921 | 248.3 K to 211.9 K (-14.63 %) |
Mar 17 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 2.75 | 36,330 | 99,908 | 248,251 | 211.9 K to 248.3 K (+17.14 %) |
Mar 15 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | M | 0.00 | 87,719 | 0 | 263,158 | |
Mar 15 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Buy | M | 0.00 | 87,719 | 0 | 87,719 | 0 to 87.7 K |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Patel Chirag K. | President & Co-CEO | Option Exercise | A | 0.00 | 926,640 | 0 | 926,640 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Patel Chintu | Co-CEO | Option Exercise | A | 0.00 | 926,640 | 0 | 926,640 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | A | 0.00 | 289,576 | 0 | 289,576 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | Konidaris Tasos | Executive Vice Pres ... | Option Exercise | A | 0.00 | 144,788 | 0 | 144,788 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 250,966 | 0 | 250,966 | |
Mar 03 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | A | 0.00 | 125,483 | 0 | 125,483 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 0.00 | 11,729 | 0 | 23,457 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Option Exercise | M | 0.00 | 35,620 | 0 | 106,860 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Payment of Exercise | F | 5.18 | 3,607 | 18,684 | 211,921 | 215.5 K to 211.9 K (-1.67 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 0.00 | 11,729 | 0 | 215,528 | 203.8 K to 215.5 K (+5.76 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Payment of Exercise | F | 5.39 | 11,548 | 62,244 | 203,799 | 215.3 K to 203.8 K (-5.36 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Shah Nikita | Executive Vice Pres ... | Buy | M | 0.00 | 35,620 | 0 | 215,347 | 179.7 K to 215.3 K (+19.82 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Option Exercise | M | 0.00 | 16,490 | 0 | 49,473 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Payment of Exercise | F | 5.39 | 5,796 | 31,240 | 10,694 | 16.5 K to 10.7 K (-35.15 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | Manzano Stephen | SVP, General Counse ... | Buy | M | 0.00 | 16,490 | 0 | 16,490 | 0 to 16.5 K |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 12,346 | 0 | 24,692 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Option Exercise | M | 0.00 | 31,662 | 0 | 94,987 | |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.18 | 6,192 | 32,075 | 131,448 | 137.6 K to 131.4 K (-4.50 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 12,346 | 0 | 137,640 | 125.3 K to 137.6 K (+9.85 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Payment of Exercise | F | 5.39 | 16,301 | 87,862 | 125,294 | 141.6 K to 125.3 K (-11.51 %) |
Mar 02 2021 | AMRX | Amneal Pharmaceuti ... | BOYER ANDREW S | Executive Vice Pres ... | Buy | M | 0.00 | 31,662 | 0 | 141,595 | 109.9 K to 141.6 K (+28.80 %) |